Fenfluramine and its effects on the sympathetic nervous system in man

References

• Babulova A., Cotillo P., Bonaccorsi A., Podvalova I. Effects of fenfluramine on the adrenergic nervous system. J. Pharm. Pharmacol. 1972; 24: 886–8931. Babulova A., Cotillo P., Bonaccorsi A., Podvalova I. Effects of fenfluramine on the adrenergic nervous system. J. Pharm. Pharmacol. 1972; 24: 886–893
   PubMed Web of Science ®Google Scholar
• Calderini G., Morselli P. L., Garattini S. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4. Eur. J. Pharmacol. 1975; 34: 345–3502. Calderini G., Morselli P. L., Garattini S. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4. Eur. J. Pharmacol. 1975; 34: 345–350
   PubMed Web of Science ®Google Scholar
• Chalmers J. P. Neuropharmacology of central mechanisms regulating blood pressure. “Central Action of Drugs in Blood Pressure Regulation”, D. S. Davies, J. L. Reid. University Park Press, London 1975; 363. Chalmers J. P. Neuropharmacology of central mechanisms regulating blood pressure. “Central Action of Drugs in Blood Pressure Regulation”, D. S. Davies, J. L. Reid. University Park Press, London 1975; 36
   Google Scholar
• Costa E., Groppetti A., Revuelta A. Action of fenfluramine on monoamine stores of rat tissues. Br. J. Pharmacol 1971; 41: 574. Costa E., Groppetti A., Revuelta A. Action of fenfluramine on monoamine stores of rat tissues. Br. J. Pharmacol 1971; 41: 57
   PubMed Web of Science ®Google Scholar
• De la Vega C. E., Slater S., Ziegler M. G., Lake C. R., Murphy D. L. Reduction in plasma norepinephrine during fenfluramine treatment. Clin. Pharmacol. Ther. 1977; 21: 216–2215. De la Vega C. E., Slater S., Ziegler M. G., Lake C. R., Murphy D. L. Reduction in plasma norepinephrine during fenfluramine treatment. Clin. Pharmacol. Ther. 1977; 21: 216–221
   PubMed Web of Science ®Google Scholar
• Elliott B. W. A collaborative investigation of fenfluramine: anorexigenic with sedative properties. Curr. Ther. Res. 1970; 12: 502–5156. Elliott B. W. A collaborative investigation of fenfluramine: anorexigenic with sedative properties. Curr. Ther. Res. 1970; 12: 502–515
   PubMed Web of Science ®Google Scholar
• Fuxe K., Farnebo L.-O., Hamberger B., Ogren S.-O. On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxy-tryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgrad. Med. J. 1975; 51: 35–45, Suppl. 17. Fuxe K., Farnebo L.-O., Hamberger B., Ogren S.-O. On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxy-tryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgrad. Med. J. 1975; 51: 35–45, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Garattini S., Buczko W., Jori A., Samanin R. The mechanism of action of fenfluramine. Postgrad. Med. J. 1975; 51: 27–35, Suppl. 18. Garattini S., Buczko W., Jori A., Samanin R. The mechanism of action of fenfluramine. Postgrad. Med. J. 1975; 51: 27–35, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Griffith J. D., Nutt J. G., Jasinski D. R. A comparison of fenfluramine and amphetamine in man. Clin. Pharmacol. Ther. 1975; 18: 563–5709. Griffith J. D., Nutt J. G., Jasinski D. R. A comparison of fenfluramine and amphetamine in man. Clin. Pharmacol. Ther. 1975; 18: 563–570
   PubMed Web of Science ®Google Scholar
• Haeusler G. Central adrenergic neurons in experimental hypertension. “Regulation of Blood Pressure by the Central Nervous System”, G. Onesti, M. Fernandes, K. E. Kim. Grune and Stratton, New York 1976; 6510. Haeusler G. Central adrenergic neurons in experimental hypertension. “Regulation of Blood Pressure by the Central Nervous System”, G. Onesti, M. Fernandes, K. E. Kim. Grune and Stratton, New York 1976; 65
   Google Scholar
• Hertting G., Axelrod J., Patrick R. W. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br. J. Pharmacol. 1961; 18: 1–611. Hertting G., Axelrod J., Patrick R. W. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br. J. Pharmacol. 1961; 18: 1–6
   Google Scholar
• Hertting G., Axelrod J., Whitby L. G. Effect of drugs on the uptake and metabolism of H3-norepinephrine. J. Pharmacol. Exp. Ther. 1961; 134: 146–15312. Hertting G., Axelrod J., Whitby L. G. Effect of drugs on the uptake and metabolism of H3-norepinephrine. J. Pharmacol. Exp. Ther. 1961; 134: 146–153
   PubMed Web of Science ®Google Scholar
• Knapp S., Mandell A. J. Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: effects of fenfluramine. J. Pharmacol. Exp. Ther. 1976; 198: 123–13213. Knapp S., Mandell A. J. Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: effects of fenfluramine. J. Pharmacol. Exp. Ther. 1976; 198: 123–132
   PubMed Web of Science ®Google Scholar
• Kobinger W. Central modulation of cardiovascular activity by clonidine and other adrenergic substances. “Regulation of Blood Pressure by the Central Nervous System”, G. Onesti, M. Fernandes, K. E. Kim. Grune and Stratton, New York 1976; 28314. Kobinger W. Central modulation of cardiovascular activity by clonidine and other adrenergic substances. “Regulation of Blood Pressure by the Central Nervous System”, G. Onesti, M. Fernandes, K. E. Kim. Grune and Stratton, New York 1976; 283
   Google Scholar
• Lake C. R., Ziegler M. G., Coleman M. D., Kopin I. J. A rationale for combined drug therapy in hypertension. Am. Soc. Nephrology 1977; 50A, Abstracts15. Lake C. R., Ziegler M. G., Coleman M. D., Kopin I. J. A rationale for combined drug therapy in hypertension. Am. Soc. Nephrology 1977; 50A, Abstracts
   Google Scholar
• Lake C. R., Ziegler M. G., Kopin I. J. Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci. 1976; 18: 1315–132616. Lake C. R., Ziegler M. G., Kopin I. J. Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci. 1976; 18: 1315–1326
   PubMed Web of Science ®Google Scholar
• Levin A. The non-medical misuse of fenfluramine by drug-dependent young South Africans. Postgrad. Med. J. 1975; 51: 183–185, Suppl. 117. Levin A. The non-medical misuse of fenfluramine by drug-dependent young South Africans. Postgrad. Med. J. 1975; 51: 183–185, Suppl. 1
   PubMedGoogle Scholar
• Louis W. J., Doyle A. E., Anavekar S. N. Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression. Clin. Sci. Mol. Med. 1975; 48: 239s–242s18. Louis W. J., Doyle A. E., Anavekar S. N. Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression. Clin. Sci. Mol. Med. 1975; 48: 239s–242s
   PubMedGoogle Scholar
• Murphy D. L., Slater S., De la Vega C. E., Lipper S. The serotonergic neurotransmitter system in the affective disorders - a preliminary evaluation of the antidepressant and antimanic effects of fenfluramine. “Neuropsychopharmacology”, P. Deniker, C. Radouco-Thomas, A. Villeneuve. Pergamon Press, New York 1978; 67519. Murphy D. L., Slater S., De la Vega C. E., Lipper S. The serotonergic neurotransmitter system in the affective disorders - a preliminary evaluation of the antidepressant and antimanic effects of fenfluramine. “Neuropsychopharmacology”, P. Deniker, C. Radouco-Thomas, A. Villeneuve. Pergamon Press, New York 1978; 675
   Google Scholar
• Reisin E., Abel R., Modan M., Silverberg D., Eliahou H. E., Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med. 1978; 298: 1–620. Reisin E., Abel R., Modan M., Silverberg D., Eliahou H. E., Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med. 1978; 298: 1–6
   PubMed Web of Science ®Google Scholar
• Shoulson I., Chase T. N. Fenfluramine in man: hypophagia associated with diminished serotonin turnover. Clin. Pharmacol. Ther. 1975; 17: 616–62121. Shoulson I., Chase T. N. Fenfluramine in man: hypophagia associated with diminished serotonin turnover. Clin. Pharmacol. Ther. 1975; 17: 616–621
   PubMed Web of Science ®Google Scholar
• Turner P. The human pupil as a model for clinical pharmacological investigations. J. R. Coll. Physicians Land. 1975; 9: 165–17222. Turner P. The human pupil as a model for clinical pharmacological investigations. J. R. Coll. Physicians Land. 1975; 9: 165–172
   PubMedGoogle Scholar
• van Zwieten P. A. Centrally mediated action of alpha-methyldopa. “Regulation of Blood Pressure by the Central Nervous System”, G. Onesti, M. Fernandes, K. E. Kim. Grune and Stratton, New York 1976; 29323. van Zwieten P. A. Centrally mediated action of alpha-methyldopa. “Regulation of Blood Pressure by the Central Nervous System”, G. Onesti, M. Fernandes, K. E. Kim. Grune and Stratton, New York 1976; 293
   Google Scholar
• Waal-Manning H. J., Simpson F. O. Fenfluramine in obese patients on various antihypertensive drugs, double-blind and controlled trial. Lancet 1969; 2: 1392–139524. Waal-Manning H. J., Simpson F. O. Fenfluramine in obese patients on various antihypertensive drugs, double-blind and controlled trial. Lancet 1969; 2: 1392–1395
   PubMed Web of Science ®Google Scholar
• Weinshilbaum R. M., Axelrod J. Serum dopamine-beta-hydroxylase activity. Circ. Res. 1971; 28: 307–31525. Weinshilbaum R. M., Axelrod J. Serum dopamine-beta-hydroxylase activity. Circ. Res. 1971; 28: 307–315
   PubMed Web of Science ®Google Scholar
• Wyatt R. J., Portnoy B., Kupfer D. J., Snyder F., Engelman K. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch. Gen. Psychiatry 1971; 24: 65–7026. Wyatt R. J., Portnoy B., Kupfer D. J., Snyder F., Engelman K. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch. Gen. Psychiatry 1971; 24: 65–70
   PubMed Web of Science ®Google Scholar